Sugi Predict

Sugi Predict / Compounds / Fenticlor

Fenticlor

Fenticlor

SCHEMBL318006

O=C(O)CNC(CO)(CO)CO.Oc1ccc(Cl)cc1Sc1cc(Cl)ccc1O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 4/20 0.56
▸ MEN1 O00255 3/20 0.56
▸ HPGD P15428 3/20 0.56
▸ HTT P42858 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ HSD17B10 Q99714 3/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ PLA2G1B P04054 1/20 0.56
▸ HSP90AA1 P07900 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ CYP2D6 P10635 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ HIF1A Q16665 1/20 0.56
▸ ATG4B Q9Y4P1 1/20 0.56
▸ POLB P06746 1/20 0.42
▸ ITGB2 P05107 2/20 0.40
▸ ICAM1 P05362 2/20 0.40
▸ ITGAL P20701 2/20 0.40
▸ CDK1 P06493 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triaziquone SCHEMBL19743231 0.82 MEN1 (0.37) ALOX15MEN1HPGDHTTKMT2A
Fenticlor SCHEMBL8365199 0.78 ALOX15 (0.56) ALOX15MEN1HPGDHTTKMT2A
Fenticlor SCHEMBL669070 0.77 ALOX15 (0.69) ALOX15MEN1HPGDHTTKMT2A
Fenticlor SCHEMBL733581 0.77 ALOX15 (0.69) ALOX15MEN1HPGDHTTKMT2A
Fenticlor SCHEMBL29729454 0.74 HSD17B10 (1.00) ALOX15MEN1HPGDHTTKMT2A
Fenticlor SCHEMBL23276 0.74 HSD17B10 (1.00) ALOX15MEN1HPGDHTTKMT2A
Fenticlor SCHEMBL1766066 0.74 HSD17B10 (0.69) ALOX15MEN1HPGDHTTKMT2A
Fenticlor SCHEMBL22074657 0.73 HPGD (0.80) ALOX15MEN1HPGDHTTKMT2A
Fenticlor SCHEMBL2898956 0.73 HSD17B10 (0.95) ALOX15MEN1HPGDHTTKMT2A
Fenticlor SCHEMBL8863189 0.71 HSD17B10 (0.91) ALOX15MEN1HPGDHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024143154-A1 ANTIMICROBIAL PEPTIDE AND METHOD FOR PRODUCING SAME 住友化学株式会社 2024-07-04 — — WO disclosed
CN-118202043-A Peptides with multivalent action 英图库尔公司 2024-06-14 — — CN disclosed
EP-4373838-A2 GRAM-NEGATIVE BACTERIA CONTAINING PEPTIDE SECRETION SYSTEM Board of Regents, The University of Texas System (US) 2024-05-29 — — EP disclosed
US-20240141372-A1 TRANSGENIC BANANA PLANTS HAVING INCREASED RESISTANCE TO FUSARIUM OXYSPORUM TROPICAL RACE 4 AND METHODS OF PRODUCING SAME ELO LIFE SYSTEMS 2024-05-02 — — US disclosed
WO-2024064694-A2 TRANSGENIC BANANA PLANTS HAVING INCREASED RESISTANCE TO FUSARIUM OXYSPORUM TROPICAL RACE 4 AND METHODS OF PRODUCING SAME ELO LIFE SYSTEMS (US) 2024-03-28 — — WO disclosed
US-20240058433-A1 COMPOSITIONS AND METHODS CHAIN BIOTECHNOLOGY LTD (GB) 2024-02-22 — — US disclosed
WO-2023247936-A1 COMPOSITIONS AND METHODS CHAIN BIOTECHNOLOGY LIMITED (GB) 2023-12-28 — — WO disclosed
US-20230242616-A1 CHEMOKINE-SELECTIVE CXCR4 ECTODOMAIN-DERIVED (POLY)PEPTIDE Technische Universität München (DE) 2023-08-03 — — US disclosed
US-20230218727-A1 THROMBIN C-TERMINAL PEPTIDES TO TREAT CORONA VIRAL INFECTIONS IN2CURE AB (SE) 2023-07-13 — — US disclosed
EP-4171615-A1 THROMBIN C-TERMINAL PEPTIDES TO TREAT CORONAVIRAL INFECTIONS In2Cure AB (SE) 2023-05-03 — — EP disclosed
US-5804416-A PRODUCED BACTERIALLY AND REFOLDED TO PRODUCE BIOLOGICALLY ACTIVE HOMODIMERS OR HETERODIMERS GENETICS INSTITUTE, INC. (US) 1998-09-08 — — US disclosed
WO-1998027210-A1 COMPOSITIONS AND METHODS FOR STIMULATING PANCREATIC ISLET CELL REGENERATION ZYMOGENETICS, INC. (US) 1998-06-25 — — WO disclosed
US-5756308-A NUCLEOTIDE TRIPLET AT POSITION 187 TO 189 OF NUCLEOTIDE SEQUENCE WHICH ENCODES BONE MORPHOGENIC PROTEIN-8 HAS BEEN REPLACED WITH TRIPLET ENCODING HISTIDINE GENETICS INSTITUTE, INC. (US) 1998-05-26 — — US disclosed
EP-0836646-A1 EXPRESSION OF OCEAN FISH ANTIFREEZE PEPTIDE IN A FOOD GRADE ORGANISM AND ITS APPLICATION IN FOOD PRODUCTS UNILEVER PLC (GB) 1998-04-22 — — EP disclosed
WO-1998014599-A1 CARBOXYPEPTIDASES FROM ASPERGILLUS ORYZAE AND NUCLEIC ACIDS ENCODING SAME NOVO NORDISK BIOTECH, INC. (US) 1998-04-09 — — WO disclosed
WO-1997017087-A1 STABILIZING FORMULATION FOR NGF GENENTECH, INC. (US) 1997-05-15 — — WO disclosed
WO-1997002343-A1 EXPRESSION OF OCEAN FISH ANTIFREEZE PEPTIDE IN A FOOD GRADE ORGANISM AND ITS APPLICATION IN FOOD PRODUCTS UNILEVER PLC (GB) 1997-01-23 — — WO disclosed
EP-0733108-A1 MUTANTS OF BONE MORPHOGENETIC PROTEINS GENETICS INSTITUTE, INC. (US) 1996-09-25 — — EP disclosed
WO-1995016034-A1 MUTANTS OF BONE MORPHOGENETIC PROTEINS GENETICS INSTITUTE, INC. (US) 1995-06-15 — — WO disclosed
US-5399677-A Recombinant DNA molecules encoding mutant forms of the proteins; purified bone morphogenetic protein heterodimers GENETICS INSTITUTE, INC. (US) 1995-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242616-A1 CHEMOKINE-SELECTIVE CXCR4 ECTODOMAIN-DERIVED (POLY)PEPTIDE CXCR4, CXCR3, CXCR1 ALOX15 3627/4885MEN1 4023/4885HPGD 3919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.